Seagen Inc.
BCMA antibodies and use of same to treat cancer and immunological disorders

Last updated:

Abstract:

The invention provides humanized antibodies that specifically bind to BCMA. The antibodies are useful for treatment and diagnoses of various cancers and immune disorders as well as detecting BCMA.

Status:
Grant
Type:

Utility

Filling date:

14 May 2019

Issue date:

3 Aug 2021